Risperidone 2 mg

DRUG3 trials

Sponsors

Pfizer, Louisiana State University Health Sciences Center Shreveport, Hasanuddin University

Conditions

ApathyCognitive DysfunctionInflamationPsychotic DisordersSchizophreniaSchizophrenia; Psychosis

Phase 2

Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia

CompletedNCT07477301

Hasanuddin UniversityCognitive Dysfunction, Inflamation, Schizophrenia

Start: 2024-12-01End: 2025-02-28Updated: 2026-03-17

Phase 3

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

RecruitingNCT06482554

Louisiana State University Health Sciences Center ShreveportApathy, Schizophrenia, Schizophrenia; Psychosis

Start: 2024-06-30End: 2026-12-31Target: 80Updated: 2024-07-01

Unknown Phase

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

CompletedNCT00174200

PfizerPsychotic Disorders, Schizophrenia

Start: 2004-12-31End: 2006-05-31Target: 20Updated: 2008-07-15